Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365989 · ClinicalTrials.gov registry record · Phase 3
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Phase 3 study, sponsored by InSightec.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT00365989 is a Phase 3 study that has completed, run by InSightec. The registered enrollment target is 50 participants.
The verdict
NCT00365989, a Phase 3 study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.
Interventions
- DEVICE ExAblate Enhanced Sonication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00365989
The ClinicalTrials.gov registry entry for NCT00365989 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExAblate Enhanced Sonication is the first listed.
NCT00365989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00365989 about?
NCT00365989 is a clinical study titled "MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication". This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.
What is the current status of trial NCT00365989?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2006-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00365989?
The interventions under investigation include: ExAblate Enhanced Sonication (DEVICE).
Who is sponsoring clinical trial NCT00365989?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.